|
Kenneth M. Bate joined NitroMed, Inc. as chief operating officer and chief financial officer in March 2006. He was named CEO in January, 2007. From 2002 to January 2005, Mr. Bate was head of commercial operations and chief financial officer at Millennium Pharmaceuticals, Inc. In 1999, Mr. Bate co-founded JSB Partners, an investment banking and transaction advisory firm serving the biopharmaceutical industry. He was a partner at JSB Partners through 2002. From 1997 to 1999, Mr. Bate served as senior managing director and chief executive officer of MPM Capital, LP, a venture capital company. He was also an advisor to BB Bioventures, a venture capital fund. Mr. Bate’s life sciences industry experience also includes six years at Biogen (now Biogen IDEC); from 1993 to 1996 as the company’s vice president of sales and marketing, and as Chief Financial Officer from 1990 to 1993. Mr. Bate is a director and serves on the boards of Cubist Pharmaceuticals, Inc. and Coley Pharmaceutical Group. Mr. Bate received his B.A. degree in Chemistry from Williams College, and an MBA from The Wharton School of the University of Pennsylvania. | 